Zensar Technologies net profit flat at ₹182 crore in Q2; revenue up 3% sequentially

Among business segments, Banking and Financial Services delivered a sequential growth of 5.6% and a year-on-year rise of 11.0% in reported currency. Healthcare and Life Sciences grew 3.9% sequentially and 11.3% year-on-year. Shares of Zensar Technologies Ltd ended at ₹795.00, down by ₹7.70, or 0.96%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *